Integrin α3/α6 and αV are implicated in ADAM15-activated FAK and EGFR signalling pathway individually and promote non-small-cell lung cancer progression

類似資料

• Abnormally activated OPN/integrin αVβ3/FAK signalling is responsible for EGFR-TKI resistance in EGFR mutant non-small-cell lung cancer
  著者:: Fu, Yulong, 等
  出版事項: (2020)
• CD151 drives cancer progression depending on integrin α3β1 through EGFR signaling in non-small cell lung cancer
  著者:: Zhu, Jianjie, 等
  出版事項: (2021)
• ALCAP2 inhibits lung adenocarcinoma cell proliferation, migration and invasion via the ubiquitination of β-catenin by upregulating the E3 ligase NEDD4L
  著者:: Zhang, Weijie, 等
  出版事項: (2021)
• Anlotinib can overcome acquired resistance to EGFR‐TKIs via FGFR1 signaling in non‐small cell lung cancer without harboring EGFR T790M mutation
  著者:: Lian, Zengzhi, 等
  出版事項: (2020)
• The canonical TGF-β/Smad signalling pathway is involved in PD-L1-induced primary resistance to EGFR-TKIs in EGFR-mutant non-small-cell lung cancer
  著者:: Zhang, Yang, 等
  出版事項: (2019)